핵산 분리 및 정제 시장 : 동향과 예측(-2035년) - 제품 유형별, 핵산별, 용액별, 정제 방법별, 샘플별, 프로세스별, 용도별, 최종사용자별, 지역별, 주요 기업별

Nucleic Acid Isolation and Purification Market: Trends and Forecast Till 2035 - Distribution by Type of Product, Nucleic Acid, Solution, Purification Method, Sample, Process, Application, End User, Geographical Regions, and Leading Players

US $ 4,799 ￦ 7,011,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,999 ￦ 10,225,000

PDF (One-Location Site License)

PDF 보고서를 동일 사업장의 특정 사업 부문에 속한 모든 분들이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,599 ￦ 15,485,000

PDF (Department License)

PDF 보고서를 부서 단위로 12명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 17,999 ￦ 26,296,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

핵산 분리 및 정제 시장 : 개요

Roots Analysis의 조사에 따르면, 핵산 분리 및 정제 시장 규모는 2035년까지 예측 기간 동안 CAGR 6.9%로 성장하여 현재 54억 1,000만 달러에서 2035년까지 105억 2,000만 달러에 달할 것으로 예측됩니다.

핵산 분리 및 정제 시장 : 성장과 트렌드

핵산 분리 및 정제 시장은 차세대 시퀀싱 기술의 보급 확대와 분자생물학 분야 관계자들의 관심 증가를 배경으로 전 세계적으로 빠르게 성장하고 있습니다. 또한, RNA 치료제 발굴 및 개발을 위한 연구개발 투자 증가도 시장 성장에 기여하고 있습니다. 또한, 만성 질환의 유병률 증가는 핵산 분리 및 정제 제품에 대한 수요 증가에 기여하고 있습니다. 미국 질병예방통제센터(CDC) 보고서에 따르면, 65세 이상 성인의 90% 이상이 적어도 한 가지 이상의 만성질환을 앓고 있다고 합니다. 또한 세계보건기구(WHO) 자료에 따르면 전 세계 사망 원인의 약 75%가 만성질환에 기인한다고 합니다.

또한, 환자별 유전자 프로파일링에 크게 의존하는 개인 맞춤형 의료에 대한 수요 증가도 시장을 견인하고 있습니다. 이러한 유전자 프로파일링을 위해서는 다양한 시료 유형에서 순환 유리 DNA, 마이크로 RNA, 엑솜을 효율적으로 추출하는 것이 필수적입니다. 또한, 추출 방법의 기술 및 자동화의 발전은 시장의 추가 확장을 촉진하고 있습니다. 자기 기반 정제 및 마이크로플루이딕스 시스템과 같은 기술은 처리 시간을 크게 단축하고 오류를 줄입니다. 시장 내 많은 기업들이 혁신적인 제품 도입, 첨단 정제 솔루션 창출을 위한 파트너십 및 공동 연구 형성 등 적극적인 노력을 기울이고 있습니다. 다양한 시료 유형에서 획기적인 신약개발 및 진단 솔루션 개발에 집중하는 업계 관계자들이 증가함에 따라, 핵산 분리 및 정제 분야는 향후 견고한 CAGR을 보일 것으로 예측됩니다.

성장 요인: 시장 확대의 전략적 원동력

임상용 차세대 염기서열 분석(NGS)에 대한 수요가 증가함에 따라, 특히 종양학 프로세스 및 액체 생검 분야에서 고품질 핵산 추출에 대한 필요성이 증가하고 있습니다. 국가 유전체 프로젝트와 분자생물학 분야의 연구개발 자금 증가는 샘플 처리 능력을 향상시키고, 멀티오믹스 연구를 촉진할 것입니다. 워크플로우 자동화, 하이스루풋 플랫폼 활용, 합성생물학의 발전, CRISPR 기술의 적용도 효율성과 재현성을 높여 도입이 가속화되고 있습니다.

시장 과제: 발전을 가로막는 심각한 장벽들

세계 핵산 정제 시장은 괄목할 만한 성장세를 보이고 있지만, 이 산업의 발전을 저해할 수 있는 제약도 존재합니다. 장비, 시약 및 키트의 고가 특성으로 인해 특히 소규모 실험실 및 신흥 시장에서 사용 가능성을 제한하고 있습니다. 또한, 수지 및 실리카 공급망에서공급 부족과 개발도상국에서공급 부족으로 인해 확장에 어려움을 겪고 있습니다. 또한, 엄격한 규제, 시료의 가변성, 숙련된 인력 부족, 폐기물 처리 의무도 핵산 정제 분야의 운영상의 문제를 야기하고 있습니다.

핵산 분리 및 정제 시장 : 주요 연구 결과

이 보고서는 핵산 분리 및 정제 시장의 현황을 상세하게 분석하고 업계의 잠재적인 성장 기회를 파악합니다. 주요 조사 결과는 다음과 같습니다.

• 현재 전 세계적으로 약 370개 업체가 핵산 분리 및 정제 제품을 제공하고 있으며, 특히 약 45%가 아시아태평양에 기반을 두고 있습니다.

• 핵산 분리 및 정제 공급업체의 약 35%는 전혈 세포, 무세포 샘플, 배양 세포, FFPE 조직 등 다양한 샘플 유형에서 DNA/RNA 추출을 위한 장비를 제공합니다.
• 감염병 발생률 증가와 자동화 보급 확대가 맞물려 핵산 분리 및 정제 시장을 견인하고 있으며, 가까운 시일 내에 꾸준한 성장이 예상됩니다.
• 분자진단 및 유전체 연구의 발전을 감안할 때, 핵산 분리 및 정제 시장은 2035년까지 연평균 복합 성장률(CAGR) 6.9%로 확대될 것으로 예측됩니다.
• 현재 전혈 세포에서 핵산 추출에 사용할 수 있는 제품 유형이 시장의 대부분을 차지하고 있습니다. 또한, 추출은 주로 응용 검사 및 감염 검사를 목적으로 합니다.
• 현재 핵산 분리 및 정제 시장의 대부분은 학술 기관 최종 사용자가 차지하고 있으며, 특히 북미가 가장 큰 시장 점유율을 차지하고 있습니다.
• 미국의 핵산 분리 및 정제 시장은 만성 질환의 유병률 증가와 분자진단에 대한 관심 증가로 인해 2035년까지 연평균 6.8%의 성장률을 보일 것으로 예측됩니다.

• 핵산 분리 및 정제 시장은 2035년까지 약 6.9%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측되며, 시장 점유율의 대부분(약 30%)을 미국이 차지할 것으로 예측됩니다.

• 분자진단에 대한 관심 증가, 연구개발비 증가, 기술 발전 등을 배경으로 핵산 분리 및 정제 산업은 향후 성장을 위한 좋은 위치에 있습니다.

핵산 정제 시장

시장 규모 및 기회 분석은 다음 매개 변수를 기반으로 세분화됩니다.

제품 유형별

• 키트
• 시약
• 장비

핵산 유형별

• DNA
• RNA

솔루션 유형별

• 수동
• 자동화

정제 방법 유형별

• 마그네틱 베이스
• 컬럼 베이스
• 시약 베이스
• 기타

샘플 유형별

• 전혈 세포
• 배양 세포
• 세균
• 포유류 세포
• 효모
• FFPE
• 뇌와 신장
• 조직
• 기타 조직
• 혈장
• 소변
• 기타 셀프리더블유 샘플
• 타액
• 기타

프로세스 유형별

• 업스트림 공정
• 다운스트림 프로세스
• PCR
• dPCR
• 차세대 시퀀싱

용도별

• 종양학 조사
• 종양학 검사
• 응용검사
• 인적 식별(HID)
• 감염병 검사
• 마이크로바이옴 검사
• 기타

최종 사용자별

• 바이오의약품
• CDMO
• CRO
• CMO
• 학술기관
• 연구기관
• 암센터
• 대학병원
• 코어랩
• 정부연구소
• 병원체표준연구소

지역별

• 북미
• 미국
• 캐나다
• 유럽
• 독일
• 프랑스
• 이탈리아
• 영국
• 스위스
• 기타 유럽
• 아시아태평양 및 기타 지역
• 중국
• 일본
• 한국
• 인도
• 호주
• 기타 아시아태평양
• 중동 및 북아프리카
• 사우디아라비아
• 아랍에미리트
• 기타 중동 및 아프리카
• 라틴아메리카
• 브라질
• 아르헨티나
• 기타 라틴아메리카 국가

핵산 분리 및 정제 시장 : 주요 부문

키트가 핵산 분리 및 정제 시장에서 가장 큰 점유율을 차지합니다.

핵산 분리 및 정제 시장 분석에 따르면, 키트 부문은 시장 점유율의 약 65%를 차지합니다. 이러한 증가는 초기 비용과 지속적인 유지보수 비용이 많이 드는 장비에 비해 키트가 비용 효율적이고 쉽게 구할 수 있기 때문입니다. 또한, 감염 검사, 종양 검사, 마이크로바이옴 검사 등 다양한 진단 용도로의 사용 확대에 따라 키트 부문은 향후 더 높은 CAGR을 보일 것으로 예측됩니다.

자기 정제 부문이 향후 가장 큰 점유율을 차지할 것입니다.

핵산 분리 및 정제 시장 예측에 따르면, 자기 정제 솔루션에 초점을 맞춘 부문이 시장을 주도하고 있습니다. 이 방법은 자동화와의 호환성, 빠른 처리, 효율성, 고순도 수준을 제공하기 때문입니다. 자기 정제를 이용한 핵산 추출 솔루션은 그 장점과 다양한 시료 유형에 대한 범용성으로 인해 향후 10년간 괄목할 만한 성장률을 보일 것으로 예측됩니다.

북미가 시장을 독점하고 가장 높은 점유율 확보

북미는 핵산 분리 및 정제 시장의 40% 이상을 차지하고 있습니다. 미국 내 의료비 지출 증가, 선진화된 인프라, 광범위한 실험실 네트워크, 감염성 및 유전성 질환의 발생률 증가 등이 이 분야에서 이 지역이 우위를 점하는 주요 요인으로 꼽힙니다.

핵산 정제 시장의 대표적인 진출기업들

• Bio-Rad
• Danaher
• Macherey-Nagel
• Merck KgaA
• Norgen Biotek
• Perkin Elmer
• Promega
• Qiagen
• Roche
• Thermo Fisher Scientific

핵산 정제 시장 : 조사 범위

• 시장 규모 및 기회 분석 : 이 보고서는 핵산 정제 시장에 대한 자세한 분석을 제공하고 주요 시장 세분화에 중점을 둡니다. 제품 유형, 핵산 유형, 솔루션 유형, 정제 방법 유형, 샘플 유형, 공정 유형, 용도 유형, 최종 사용자, 지리적 지역, 주요 기업, 주요 시장 기업에 대한 상세한 분석을 수록했으며, 핵산 정제 시장에 대한 상세한 분석을 제공합니다. 제공합니다.
• 시장 상황: 핵산 분리 및 정제 제품 제공 기업 전체 시장 상황에 대한 자세한 개요와 함께(A) 설립 연도,(B) 기업 규모,(C) 본사 소재지,(D) 제품 유형,(E) 핵산 유형,(F) 샘플 유형,(G) 솔루션 유형,(H) 정제 방법 유형,(I) 공정 유형,(J) 최종 사용자,(K) 용도 유형. 최종사용자,(K)용도 유형.
• 기업 프로파일: 북미, 유럽, 아시아태평양에서 핵산 분리 및 정제 제품을 제공하는 주요 기업의 상세한 프로파일을(A) 설립연도,(B) 본사 소재지,(C) 제품 포트폴리오,(D) 최근 동향,(E) 향후 전망에 근거하여 제공합니다.
• 시장 영향 분석 : 세계 핵산 정제 시장의 성장에 영향을 미칠 수 있는 요인에 대한 상세한 분석입니다. 또한,(A) 주요 촉진요인,(B) 잠재적 제약 요인,(C) 새로운 기회,(D) 기존 과제 파악 및 분석도 포함됩니다.

목차

섹션 I : 보고서 개요

제1장 배경

제2장 조사 방법

제3장 시장 역학

제4장 거시경제 지표

섹션 II : 정성적 인사이트

제5장 주요 요약

제6장 서론

• 핵산 분리와 정제 개요
• 핵산 분리와 정제 역사적 진화
• 핵산 분리 및 정제 방법 유형
• 핵산 분리와 정제 응용
• 향후 전망

섹션 III : 시장 개요

제7장 핵산 분리 및 정제 제품 프로바이더 시장 구도

• 조사 방법과 주요 파라미터
• 핵산 분리 및 정제 제품 프로바이더 : 시장 구도
• 핵산 분리 및 정제 제품 프로바이더 상위 50사 : 시장 구도

섹션 IV : 기업 개요

제8장 기업 개요

• 본 장의 개요
• Agilent
• AccuBioMed
• Bio-Rad
• CleanNA
• Danaher
• Favorgen Biotech
• Kurabo
• Merck KGaA
• Perkin Elmer
• Promega
• Qiagen
• Roche
• Thermo Fisher Scientiifc

섹션 V : 시장 예측과 기회 분석

제9장 시장 영향 분석 : 촉진요인, 억제요인, 기회, 과제

• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회
• 시장이 해결해야 할 과제

제10장 세계의 핵산 분리 및 정제 시장

제11장 핵산 분리 및 정제 시장 : 제품 유형별

제12장 핵산 분리 및 정제 시장 : 핵산 유형별

제13장 핵산 분리 및 정제 시장 : 용액 유형별

제14장 핵산 분리 및 정제 시장 : 정제 방법별

제15장 핵산 분리 및 정제 시장 : 샘플 유형별

제16장 핵산 분리 및 정제 시장 : 프로세스별

제17장 핵산 분리 및 정제 시장 : 용도별

제18장 핵산 분리 및 정제 시장 : 최종사용자별

제19장 핵산 분리 및 정제 시장 : 지역별

섹션 VI : 지역 시장 기회 분석

제20장 시장 기회 분석 : 북미

제21장 시장 기회 분석 : 유럽

제22장 시장 기회 분석 : 아시아태평양

제23장 시장 기회 분석 : 중동 및 북아프리카

제24장 시장 기회 분석 : 라틴아메리카

제25장 핵산 분리 및 정제 시장 : 주요 기업별

• 주요 전제와 조사 방법
• 핵산 분리 및 정제 시장 : 주요 기업별 시장
• 데이터 삼각측량과 검증

제26장 결론

제27장 부록 I : 표 데이터

제28장 부록 II : 기업 리스트

LSH

영문 목차

영문목차

Nucleic Acid Isolation and Purification Market: Overview

As per Roots Analysis, the nucleic acid isolation and purification market is estimated to grow from USD 5.41 billion in the current year to USD 10.52 billion by 2035, at a CAGR of 6.9% during the forecast period, till 2035.

Nucleic Acid Isolation and Purification Market: Growth and Trends

The nucleic acid isolation and purification market is experiencing rapid growth globally, fueled by the increasing adoption of next-generation sequencing technologies, and heightened interest of players in molecular biology. Further, the rising research and development investments aimed at the discovery and development of RNA therapeutics are also contributing to market growth. Furthermore, the rising prevalence of chronic diseases is contributing to the higher demand for nucleic acid isolation and purification products. According to a report by the Centers for Disease Control and Prevention, more than 90% of adults aged 65 and older suffer from at least one chronic condition. In addition, data from the World Health Organization indicates that roughly 75% of deaths worldwide are attributed to chronic diseases.

The market is also propelled by the growing need for personalized medicine, which relies heavily on patient-specific genetic profiling. In addition, this genetic profiling necessitates efficient extraction of circulating free DNA, miRNA, and exosomes from various sample types. Additionally, advancements in technology and automation in extraction methods are further driving market expansion. Techniques such as magnetic-based purification and microfluidic systems considerably reduce processing times and lessen errors. Many companies in the market are actively engaging in initiatives, including the introduction of innovative products and forming partnerships and collaborations to create advanced purification solutions. As an increasing number of industry players concentrate on developing groundbreaking drug discovery and diagnostic solutions from a diverse range of sample types, it is anticipated that the nucleic acid isolation and purification sector will see a robust compound annual growth rate in the future.

Growth Drivers: Strategic Enablers of Market Expansion

The rise in demand for clinical-grade NGS has increased the necessity for high-quality nucleic acid extraction, especially in oncology processes and liquid biopsy applications. National genomics initiatives and a boost in research and development funding in molecular biology enhance sample throughput and facilitate multi-omics research. The automation of workflows, the use of high-throughput platforms, advancements in synthetic biology, and the application of CRISPR are also speeding up the adoption by enhancing efficiency and reproducibility.

Market Challenges: Critical Barriers Impeding Progress

While the global nucleic acid purification market is experiencing substantial growth, there are certain restraints that can hinder the growth of this industry. The expensive nature of instruments, reagents, and kits restricts availability, particularly for smaller laboratories and emerging markets. Further, cin the supply chain for resins and silica, combined with limited access in developing areas, obstructs expansion. Further, stringent regulations, variability in samples, a shortage of skilled workers, and waste disposal mandates also introduce operational challenges in the nucleic acid purification domain.

Nucleic Acid Isolation and Purification Market: Key Insights

The report delves into the current state of the nucleic acid isolation and purification market and identifies potential growth opportunities within industry. Some key findings from the report include:

• At present, ~370 companies are engaged in offering nucleic acid isolation and purification products across the globe; notably, close to 45% of such companies are based in Asia-Pacific region.

• ~35% of the nucleic acid isolation and purification providers are offering instruments for extraction of DNA / RNA from a variety of sample types, including whole blood cells, cell-free samples, cultured cells and FFPE tissues.
• The growing incidence of infectious diseases coupled with rising adoption of automation, drives the market for nucleic acid isolation and purification, positioning it for steady growth in the foreseeable future.
• Given the advancements in molecular diagnostics and genomics research, the market for nucleic acid isolation and purification is anticipated to grow at an annualized rate (CAGR) of 6.9% till 2035.
• Currently, product types that can be used for nucleic acid extraction from whole blood cells occupy majority share of the market; further, the extraction is primarily intended for applied and infectious disease testing purposes.
• At present, majority of the nucleic acid isolation and purification market is captured by academic end users; notably, North America captures the largest share of the market.
• The US nucleic acid isolation and purification market, driven by rising prevalence of chronic disorders and interest in molecular diagnostics is anticipated to grow at a CAGR of 6.8% by 2035.

• The nucleic acid isolation and purification market is likely to grow at an annualized rate (CAGR) of ~6.9%, till 2035; majority of the market share (~30%) is expected to be captured by the US.

• Given the rising interest in molecular diagnostics, along with the rising R&D expenditure and technological advancements, the nucleic acid isolation and purification industry is well-positioned for future growth.

Nucleic Acid Purification Market

The market sizing and opportunity analysis has been segmented across the following parameters:

By Type of Product

• Kits
• Reagents
• Instruments

By Type of Nucleic Acid

• DNA
• RNA

By Type of Solution

• Manual
• Automated

By Type of Purification Method

• Magnetic based
• Column based
• Reagent based
• Others

By Type of Sample

• Whole Blood Cells
• Cultured Cells
• Bacteria
• Mammalian Cells
• Yeast
• FFPE
• Brain and Kidney
• Tissues
• Other Tissues
• Plasma
• Urine
• Other Cell free Samples
• Saliva
• Others

By Type of Process

• Upstream Processing
• Downstream Processing
• PCR
• dPCR
• NGS

By Type of Application

• Oncology Research
• Oncology Testing
• Applied Testing
• Human Identification (HID)
• Infectious Disease Testing
• Microbiome Testing
• Other Applications

By End User

• Biopharma
• CDMO
• CRO
• CMO
• Academia
• Research Labs
• Cancer Centers
• University Hospitals
• Core Labs
• Government Labs
• Pathogen Reference Labs

By Geographical Regions

• North America
• US
• Canada
• Europe
• Germany
• France
• Italy
• UK
• Switzerland
• Rest of Europe
• Asia-Pacific and Rest of the World
• China
• Japan
• South Korea
• India
• Australia
• Rest of Asia-Pacific
• Middle East and North Africa
• Saudi Arabia
• United Arab Emirates
• Rest of Middle East & North Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Nucleic Acid Isolation and Purification Market: Key Segments

Kits Account for the Largest Nucleic Acid Isolation and Purification Market Share

According to the nucleic acid isolation and purification market analysis, the kits segment represents approximately 65% of the market share. This increase is attributed to their cost-effectiveness and easy accessibility in comparison to instruments, which involve considerable initial expenses and ongoing maintenance fees. Further, the kits segment is expected to experience a higher compound annual growth rate (CAGR) in the future, driven by their growing use in various diagnostic applications, including infectious disease testing, oncology testing, and microbiome testing among others.

Magnetic Purification Segment Hold the Highest Share in the Future

As per the forecast for the nucleic acid isolation and purification market, the segment focusing on magnetic purification solutions leads the market because this method provides automation compatibility, rapid processing, efficiency, and high purity levels. The nucleic acid extraction solutions utilizing magnetic purification are expected to experience a significant growth rate over the next decade due to their advantages and versatility across various sample types.

North America Dominates the Market by Securing Highest Share

North America holds over 40% of the market share for nucleic acid isolation and purification. Key factors driving the region's dominance in this field include increasing healthcare spending in the US, advanced infrastructure, an extensive network of laboratories, and a rising incidence of infectious diseases and genetic conditions.

Primary Research Overview

Discussions with multiple stakeholders in this domain influenced the opinions and insights presented in this study. The market report includes transcripts of the following other third-party discussions:

• Senior Vice President, Small Company in the US
• Head of Sales, Small Company in Germany
• Business Development Manager, Mid-sized Company in the US
• Business Development Executive, Mid-sized Company in Spain
• Business Development Manager, Mid-sized Company in Spain
• Business Manager, Small Company in Germany
• Assistant Manager, Mid-sized Company in India
• Marketing Manager, Small Company in the US
• Product Manager, Small Company in Netherlands
• Sales Representative, Mid-sized Company in China

Example Players in Nucleic Acid Purification Market

• Bio-Rad
• Danaher
• Macherey-Nagel
• Merck KgaA
• Norgen Biotek
• Perkin Elmer
• Promega
• Qiagen
• Roche
• Thermo Fisher Scientific

Nucleic Acid Purification Market: Research Coverage

• Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the nucleic acid purification market, focusing on key market segments, including [A] type of product, [B] type of nucleic acid, [C] type of solution, [D] type of purification method, [E] type of sample, [F] type of process, [G] type of application, [H] end user and [I] geographical regions, and [J] leading players.
• Market Landscape: A detailed overview of the overall nucleic acid isolation and purification product providers market landscape, along with information on several relevant parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, [D] type of product, [E] type of nucleic acid, [F] type of sample, [G] type of solution, [H] type of purification method, [I] type of process, [J] end user and [K] type of application.
• Company Profiles: In-depth profiles of prominent players North America, Europe and Asia-Pacific that are engaged in offering nucleic acid isolation and purification products based on [A] year of establishment, [B] location of headquarters, [C] product portfolio, [D] recent developments and [E] an informed future outlook.
• Market Impact Analysis: An in-depth analysis of the factors that can impact the growth of the global nucleic acid purification market. It also features identification and analysis of [A] key drivers, [B] potential restraints, [C] emerging opportunities, and [D] existing challenges.

Key Questions Answered in this Report

• Which are the leading companies in nucleic acid purification market?
• Which region dominates the nucleic acid purification market?
• What are the key trends observed in the nucleic acid purification market?
• What factors are likely to influence the evolution of this market?
• What are the primary challenges faced by nucleic acid purification?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?

Reasons to Buy this Report

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
• The report can aid businesses in identifying future opportunities in any sector. It also helps in understanding if those opportunities are worth pursuing.
• The report helps in identifying customer demand by understanding the needs, preferences, and behavior of the target audience in order to tailor products or services effectively.
• The report equips new entrants with requisite information regarding a particular market to help them build successful business strategies.
• The report allows for more effective communication with the audience and in building strong business relations.

Additional Benefits

• Complementary PPT Insights Pack
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 15% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

SECTION I: REPORT OVERVIEW

1. BACKGROUND

• 1.1. Context
• 1.2. Project Objectives

2. RESEARCH METHODOLOGY

• 2.1. Research Assumptions
  • 2.1.1. Market Landscape and Market Trends
  • 2.1.2. Market Forecast and Opportunity Analysis
  • 2.1.3. Comparative Analysis
• 2.2. Database Building
  • 2.2.1. Data Collection
  • 2.2.2. Data Validation
  • 2.2.3. Data Analysis
• 2.3. Project Methodology
  • 2.3.1. Project Commencement
  • 2.3.2. Secondary Research
    • 2.3.2.1. Annual Reports
    • 2.3.2.2. Academic Research Papers
    • 2.3.2.3. Company Websites
    • 2.3.2.4. Investor Presentations and Regulatory Filings
    • 2.3.2.5. White Papers
    • 2.3.2.6. Industry Publications
    • 2.3.2.7. Conferences and Seminars
    • 2.3.2.8. Government Portals
    • 2.3.2.9. Media and Press Releases
    • 2.3.2.10. Newsletters
    • 2.3.2.11. Industry and Paid Databases
    • 2.3.2.12. Roots Proprietary Databases
  • 2.3.3. Primary Research
  • 2.3.4. Data Analysis and Interpretation
  • 2.3.5. Market Forecast and Validation
  • 2.3.6. Report Compilation
• 2.4. Research Ethics and Integrity
• 2.5. Analytical Tools and Databases
• 2.6. Robust Quality Control Framework

3. MARKET DYNAMICS

• 3.1. Forecast Methodology
  • 3.1.1. Top-Down Approach
  • 3.1.2. Bottom-Up Approach
  • 3.1.3. Hybrid Approach
• 3.2. Market Assessment Framework
  • 3.2.1. Total Addressable Market (TAM)
  • 3.2.2. Serviceable Addressable Market (SAM)
  • 3.2.3. Serviceable Obtainable Market (SOM)
  • 3.2.4. Currently Acquired Market (CAM)
• 3.3. Forecasting Tools and Techniques
  • 3.3.1. Qualitative Forecasting
  • 3.3.2. Correlation
  • 3.3.3. Regression
  • 3.3.4. Extrapolation
  • 3.3.5. Convergence
  • 3.3.6. Sensitivity Analysis
  • 3.3.7. Scenario Planning
  • 3.3.8. Data Visualization
  • 3.3.9. Time Series Analysis
  • 3.3.10. Forecast Error Analysis
• 3.4. Key Considerations
  • 3.4.1. Demographics
  • 3.4.2. Economic Factors
  • 3.4.3. Competitive Landscape
  • 3.4.4. Government Regulations and Policies
  • 3.4.5. R&D Investment
  • 3.4.6. Technological Factors
  • 3.4.7. Industry Consolidation
  • 3.4.8. Supply Chain
  • 3.4.9. Market Access
  • 3.4.10. Pandemics / Unforeseen Disruptions Impact

4. MACRO-ECONOMIC INDICATORS

• 4.1. Market Dynamics
  • 4.1.1. Time Period
    • 4.1.1.1. Historical Trends
    • 4.1.1.2. Current and Forecasted Estimates
  • 4.1.2. Currency Coverage
    • 4.1.2.1. Overview of Major Currencies Affecting the Market
    • 4.1.2.2. Impact of Currency Fluctuations on the Industry
  • 4.1.3. Foreign Exchange Impact
    • 4.1.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
    • 4.1.3.2. Strategies for Mitigating Foreign Exchange Risk
  • 4.1.4. Recession
    • 4.1.4.1. Historical Analysis of Past Recessions and Lessons Learnt
    • 4.1.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
  • 4.1.5. Inflation
    • 4.1.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
    • 4.1.5.2. Potential Impact of Inflation on the Market Evolution
  • 4.1.6. Other Indicators
    • 4.1.6.1. War Impact Analysis
    • 4.1.6.2. Cross-border Dynamics
    • 4.1.6.3. Consumer Spendings and Gross Domestic Product
    • 4.1.6.4. Stock Market Performance

SECTION II: QUALITATIVE INSIGHTS

5. EXECUTIVE SUMMARY

6. INTRODUCTION

• 6.1. An Overview of Nucleic Acid Isolation and Purification
• 6.2. Historical Evolution of Nucleic Acid Isolation and Purification
• 6.3. Types of Nucleic Acid Isolation and Purification Methods
• 6.4. Applications of Nucleic Acid Isolation and Purification
• 6.5. Future Perspectives

SECTION III: MARKET OVERVIEW

7. MARKET LANDSCAPE OF NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCT PROVIDERS

• 7.1. Methodology and Key Parameters
• 7.2. Nucleic Acid Isolation And Purification Product Providers: Market Landscape
  • 7.2.1. Analysis by Year of Establishment
  • 7.2.2. Analysis by Company Size
  • 7.2.3. Analysis by Location of Headquarters
  • 7.2.4. Analysis by Type of Product
  • 7.2.5. Analysis by Type of Nucleic Acid
  • 7.2.6. Analysis by Type of Sample
• 7.3. Top 50 Nucleic Acid Isolation And Purification Product Providers: Market Landscape
  • 7.3.1. Analysis by Type of Solution
  • 7.3.2. Analysis by Type of Purification Method
  • 7.3.3. Analysis by Type of Process
  • 7.3.4. Analysis by End User
  • 7.3.5. Analysis by Type of Application

SECTION IV: COMPANY PROFILES

8. COMPANY PROFILES

• 8.1. Chapter Overview
• 8.2. Agilent
  • 8.2.1. Company Overview
  • 8.2.2. Financial Information
  • 8.2.3. Product Portfolio
  • 8.2.4. Recent Developments and Future Outlook
• 8.2. AccuBioMed
• 8.3. Bio-Rad
• 8.4. CleanNA
• 8.5. Danaher
• 8.6. Favorgen Biotech
• 8.7. Kurabo
• 8.8. Merck KGaA
• 8.9. Perkin Elmer
• 8.10. Promega
• 8.11. Qiagen
• 8.12. Roche
• 8.13. Thermo Fisher Scientiifc

SECTION V: MARKET FORECAST AND OPPORTUNITY ANALYSIS

9. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

• 9.1. Market Drivers
• 9.2. Market Restraints
• 9.3. Market Opportunities
• 9.4. Market Challenges

10. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET

• 10.1. Key Assumptions and Methodology
• 10.2. Global Nucleic Acid Isolation and Purification Market, Forecasted Estimates (till 2035)
  • 10.2.1. Multivariate Scenario Analysis
    • 10.2.1.1. Conservative Scenario
    • 10.2.1.2. Optimistic Scenario
• 10.3. Key Market Segmentations

11. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE OF PRODUCT

• 11.1. Key Assumptions and Methodology
• 11.2. Nucleic Acid Isolation and Purification Market: Distribution by Type of Product
  • 11.2.1. Nucleic Acid Isolation and Purification Market for Kits, Forecasted Estimates (till 2035)
  • 11.2.2. Nucleic Acid Isolation and Purification Market for Instruments, Forecasted Estimates (till 2035)
  • 11.2.3. Nucleic Acid Isolation and Purification Market for Reagents, Forecasted Estimates (till 2035)
• 11.3. Data Triangulation and Validation

12. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE OF NUCLEIC ACID

• 12.1. Key Assumptions and Methodology
• 12.2. Nucleic Acid Isolation and Purification Market: Distribution by Type of Nucleic Acid
  • 12.2.1. Nucleic Acid Isolation and Purification Market for DNA, Forecasted Estimates (till 2035)
  • 12.2.2. Nucleic Acid Isolation and Purification Market for RNA, Forecasted Estimates (till 2035)
• 12.3. Data Triangulation and Validation

13. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE OF SOLUTION

• 13.1. Key Assumptions and Methodology
• 13.2. Nucleic Acid Isolation and Purification Market: Distribution by Type of Solution
  • 13.2.1. Nucleic Acid Isolation and Purification Market for Manual Solutions, Forecasted Estimates (till 2035)
  • 13.2.2. Nucleic Acid Isolation and Purification Market for Automated Solutions, Forecasted Estimates (till 2035)
• 13.3. Data Triangulation and Validation

14. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE OF PURIFICATION METHOD

• 14.1. Key Assumptions and Methodology
• 14.2. Nucleic Acid Isolation and Purification Market: Distribution by Type of Purification Method
  • 14.2.1. Nucleic Acid Isolation and Purification Market for Magnetic-based Methods, Forecasted Estimates (till 2035)
  • 14.2.2. Nucleic Acid Isolation and Purification Market for Column-based Methods, Forecasted Estimates (till 2035)
  • 14.2.3. Nucleic Acid Isolation and Purification Market for Reagent-based Methods, Forecasted Estimates (till 2035)
  • 14.2.4. Nucleic Acid Isolation and Purification Market for Other Methods, Forecasted Estimates (till 2035)
• 14.3. Data Triangulation and Validation

15. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE OF SAMPLE

• 15.1. Key Assumptions and Methodology
• 15.2. Nucleic Acid Isolation and Purification Market: Distribution by Type of Sample
  • 15.2.1. Nucleic Acid Isolation and Purification Market for Whole Blood Cells, Forecasted Estimates (till 2035)
  • 15.2.2. Nucleic Acid Isolation and Purification Market for Cultured Cells, Forecasted Estimates (till 2035)
  • 15.2.3. Nucleic Acid Isolation and Purification Market for Bacteria, Forecasted Estimates (till 2035)
  • 15.2.4. Nucleic Acid Isolation and Purification Market for Mammalian Cells, Forecasted Estimates (till 2035)
  • 15.2.5. Nucleic Acid Isolation and Purification Market for Yeast, Forecasted Estimates (till 2035)
  • 15.2.6. Nucleic Acid Isolation and Purification Market for FFPE, Forecasted Estimates (till 2035)
  • 15.2.7. Nucleic Acid Isolation and Purification Market for Brain and Kidney Tissues, Forecasted Estimates (till 2035)
  • 15.2.8. Nucleic Acid Isolation and Purification Market for Other Tissues, Forecasted Estimates (till 2035)
  • 15.2.9. Nucleic Acid Isolation and Purification Market for Plasma, Forecasted Estimates (till 2035)
  • 15.2.10. Nucleic Acid Isolation and Purification Market for Urine, Forecasted Estimates (till 2035)
  • 15.2.11. Nucleic Acid Isolation and Purification Market for Other Cell-free Samples, Forecasted Estimates (till 2035)
  • 15.2.12. Nucleic Acid Isolation and Purification Market for Saliva, Forecasted Estimates (till 2035)
  • 15.2.13. Nucleic Acid Isolation and Purification Market for Others, Forecasted Estimates (till 2035)
• 15.3. Data Triangulation and Validation

16. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE OF PROCESS

• 16.1. Key Assumptions and Methodology
• 16.2. Nucleic Acid Isolation and Purification Market: Distribution by Type of Process
  • 16.2.1. Nucleic Acid Isolation and Purification Market for Upstream Processing, Forecasted Estimates (till 2035)
  • 16.2.2. Nucleic Acid Isolation and Purification Market for Downstream Processing, Forecasted Estimates (till 2035)
• 16.3. Data Triangulation and Validation

17. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE OF APPLICATION

• 17.1. Key Assumptions and Methodology
• 17.2. Nucleic Acid Isolation and Purification Market: Distribution by Type of Application
  • 17.2.1. Nucleic Acid Isolation and Purification Market for Oncology Research, Forecasted Estimates (till 2035)
  • 17.2.2. Nucleic Acid Isolation and Purification Market for Oncology Testing, Forecasted Estimates (till 2035)
  • 17.2.3. Nucleic Acid Isolation and Purification Market for Applied Testing, Forecasted Estimates (till 2035)
  • 17.2.4. Nucleic Acid Isolation and Purification Market for Human Identification (HID), Forecasted Estimates (till 2035)
  • 17.2.5. Nucleic Acid Isolation and Purification Market for Infectious Disease Testing, Forecasted Estimates (till 2035)
  • 17.2.6. Nucleic Acid Isolation and Purification Market for Microbiome Testing, Forecasted Estimates (till 2035)
  • 17.2.7. Nucleic Acid Isolation and Purification Market for Other Application Areas, Forecasted Estimates (till 2035)
• 17.3. Data Triangulation and Validation

18. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY ENS USER

• 18.1. Key Assumptions and Methodology
• 18.2. Nucleic Acid Isolation and Purification Market: Distribution by End User
  • 18.2.1. Nucleic Acid Isolation and Purification Market for Biopharma End Users, Forecasted Estimates (till 2035)
  • 18.2.2. Nucleic Acid Isolation and Purification Market for Academia End Users, Forecasted Estimates (till 2035)
• 18.3. Data Triangulation and Validation

19. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY GEOGRAPHICAL REGIONS

• 19.1. Key Assumptions and Methodology
• 19.2. Nucleic Acid Isolation and Purification Market: Distribution Geographical Regions
  • 19.2.1. Nucleic Acid Isolation and Purification Market in North America, Forecasted Estimates (till 2035)
  • 19.2.2. Nucleic Acid Isolation and Purification Market in the US, Forecasted Estimates (till 2035)
  • 19.2.3. Nucleic Acid Isolation and Purification Market in Canada, Forecasted Estimates (till 2035)
  • 19.2.4. Nucleic Acid Isolation and Purification Market in Europe, Forecasted Estimates (till 2035)
  • 19.2.5. Nucleic Acid Isolation and Purification Market in Germany, Forecasted Estimates (till 2035)
  • 19.2.6. Nucleic Acid Isolation and Purification Market in France, Forecasted Estimates (till 2035)
  • 19.2.7. Nucleic Acid Isolation and Purification Market in Italy, Forecasted Estimates (till 2035)
  • 19.2.8. Nucleic Acid Isolation and Purification Market in the UK, Forecasted Estimates (till 2035)
  • 19.2.9. Nucleic Acid Isolation and Purification Market in Switzerland, Forecasted Estimates (till 2035)
  • 19.2.10. Nucleic Acid Isolation and Purification Market in Rest of the Europe, Forecasted Estimates (till 2035)
  • 19.2.11. Nucleic Acid Isolation and Purification Market in Asia-Pacific, Forecasted Estimates (till 2035)
  • 19.2.12. Nucleic Acid Isolation and Purification Market in China, Forecasted Estimates (till 2035)
  • 19.2.13. Nucleic Acid Isolation and Purification Market in Japan, Forecasted Estimates (till 2035)
  • 19.2.14. Nucleic Acid Isolation and Purification Market in South Korea, Forecasted Estimates (till 2035)
  • 19.2.15. Nucleic Acid Isolation and Purification Market in India, Forecasted Estimates (till 2035)
  • 19.2.16. Nucleic Acid Isolation and Purification Market in Australia, Forecasted Estimates (till 2035)
  • 19.2.17. Nucleic Acid Isolation and Purification Market in Rest of the Asia-Pacific, Forecasted Estimates (till 2035)
  • 19.2.18. Nucleic Acid Isolation and Purification Market in Middle East and North Africa, Forecasted Estimates (till 2035)
  • 19.2.19. Nucleic Acid Isolation and Purification Market in Saudi Arabia, Forecasted Estimates (till 2035)
  • 19.2.20. Nucleic Acid Isolation and Purification Market in UAE, Forecasted Estimates (till 2035)
  • 19.2.21. Nucleic Acid Isolation and Purification Market in Rest of the Middle East and North Africa, Forecasted Estimates (till 2035)
  • 19.2.22. Nucleic Acid Isolation and Purification Market in Latin America, Forecasted Estimates (till 2035)
  • 19.2.23. Nucleic Acid Isolation and Purification Market in Brazil, Forecasted Estimates (till 2035)
  • 19.2.24. Nucleic Acid Isolation and Purification Market in Argentina, Forecasted Estimates (till 2035)
  • 19.2.25. Nucleic Acid Isolation and Purification Market in Rest of the Latin America, Forecasted Estimates (till 2035)
• 19.3. Data Triangulation and Validation

SECTION VI: MARKET OPPORTUNITY ANALYSIS WITHIN GEOGRAPHICAL REGIONS**

20. MARKET OPPORTUNITY ANALYSIS: NORTH AMERICA

• 20.1. Nucleic Acid Isolation and Purification Market in North America: Distribution by Type of Product
  • 20.1.1. Nucleic Acid Isolation and Purification Market in North America for Kits, Forecasted Estimates (till 2035)
  • 20.1.2. Nucleic Acid Isolation and Purification Market in North America for Instruments, Forecasted Estimates (till 2035)
  • 20.1.3. Nucleic Acid Isolation and Purification Market in North America for Reagents, Forecasted Estimates (till 2035)
• 20.2. Nucleic Acid Isolation and Purification Market in North America: Distribution by Type of Nucleic Acid
  • 20.2.1. Nucleic Acid Isolation and Purification Market in North America for DNA, Forecasted Estimates (till 2035)
  • 20.2.2. Nucleic Acid Isolation and Purification Market in North America for RNA, Forecasted Estimates (till 2035)
• 20.3. Nucleic Acid Isolation and Purification Market in North America: Distribution by Type of Solution
  • 20.3.1. Nucleic Acid Isolation and Purification Market in North America for Manual Solutions, Forecasted Estimates (till 2035)
  • 20.3.2. Nucleic Acid Isolation and Purification Market in North America for Automated Solutions, Forecasted Estimates (till 2035)
• 20.4. Nucleic Acid Isolation and Purification Market in North America: Distribution by Type of Purification Method
  • 20.4.1. Nucleic Acid Isolation and Purification Market in North America for Magnetic-based Methods, Forecasted Estimates (till 2035)
  • 20.4.2. Nucleic Acid Isolation and Purification Market in North America for Column-based Methods, Forecasted Estimates (till 2035)
  • 20.4.3. Nucleic Acid Isolation and Purification Market in North America for Reagent-based Methods, Forecasted Estimates (till 2035)
  • 20.4.4. Nucleic Acid Isolation and Purification Market in North America for Other Methods, Forecasted Estimates (till 2035)
• 20.5. Nucleic Acid Isolation and Purification Market in North America: Distribution by Type of Sample
  • 20.5.1. Nucleic Acid Isolation and Purification Market in North America for Whole Blood Cells, Forecasted Estimates (till 2035)
  • 20.5.2. Nucleic Acid Isolation and Purification Market in North America for Cultured Cells, Forecasted Estimates (till 2035)
  • 20.5.3. Nucleic Acid Isolation and Purification Market in North America for Bacteria, Forecasted Estimates (till 2035)
  • 20.5.4. Nucleic Acid Isolation and Purification Market in North America for Mammalian Cells, Forecasted Estimates (till 2035)
  • 20.5.5. Nucleic Acid Isolation and Purification Market in North America for Yeast, Forecasted Estimates (till 2035)
  • 20.5.6. Nucleic Acid Isolation and Purification Market in North America for FFPE, Forecasted Estimates (till 2035)
  • 20.5.7. Nucleic Acid Isolation and Purification Market in North America for Brain and Kidney Tissues, Forecasted Estimates (till 2035)
  • 20.5.8. Nucleic Acid Isolation and Purification Market in North America for Other Tissues, Forecasted Estimates (till 2035)
  • 20.5.9. Nucleic Acid Isolation and Purification Market in North America for Plasma, Forecasted Estimates (till 2035)
  • 20.5.10. Nucleic Acid Isolation and Purification Market in North America for Urine, Forecasted Estimates (till 2035)
  • 20.5.11. Nucleic Acid Isolation and Purification Market in North America for Other Cell-free Samples, Forecasted Estimates (till 2035)
  • 20.5.12. Nucleic Acid Isolation and Purification Market in North America for Saliva, Forecasted Estimates (till 2035)
  • 20.5.13. Nucleic Acid Isolation and Purification Market in North America for Others, Forecasted Estimates (till 2035)
• 20.6. Nucleic Acid Isolation and Purification Market in North America: Distribution by Type of Process
  • 20.6.1. Nucleic Acid Isolation and Purification Market in North America for Upstream Processing, Forecasted Estimates (till 2035)
  • 20.6.2. Nucleic Acid Isolation and Purification Market in North America for Downstream Processing, Forecasted Estimates (till 2035)
• 20.7. Nucleic Acid Isolation and Purification Market in North America: Distribution by Type of Application
  • 20.7.1. Nucleic Acid Isolation and Purification Market in North America for Oncology Testing, Forecasted Estimates (till 2035)
  • 20.7.2. Nucleic Acid Isolation and Purification Market in North America for Oncology Research, Forecasted Estimates (till 2035)
  • 20.7.3. Nucleic Acid Isolation and Purification Market in North America for Applied Testing, Forecasted Estimates (till 2035)
  • 20.7.4. Nucleic Acid Isolation and Purification Market in North America for Human Identification (HID), Forecasted Estimates (till 2035)
  • 20.7.5. Nucleic Acid Isolation and Purification Market in North America for Infectious Disease Testing, Forecasted Estimates (till 2035)
  • 20.7.6. Nucleic Acid Isolation and Purification Market in North America for Microbiome Testing, Forecasted Estimates (till 2035)
  • 20.7.7. Nucleic Acid Isolation and Purification Market in North America for Other Applications, Forecasted Estimates (till 2035)
• 20.8. Nucleic Acid Isolation and Purification Market in North America: Distribution by End User
  • 20.8.1. Nucleic Acid Isolation and Purification Market in North America for Biopharma End Users, Forecasted Estimates (till 2035)
  • 20.8.2. Nucleic Acid Isolation and Purification Market in North America for Academic End Users, Forecasted Estimates (till 2035)

21. MARKET OPPORTUNITY ANALYSIS: EUROPE

• 21.1. Nucleic Acid Isolation and Purification Market in Europe: Distribution by Type of Product
  • 21.1.1. Nucleic Acid Isolation and Purification Market in Europe for Kits, Forecasted Estimates (till 2035)
  • 21.1.2. Nucleic Acid Isolation and Purification Market in Europe for Instruments, Forecasted Estimates (till 2035)
  • 21.1.3. Nucleic Acid Isolation and Purification Market in Europe for Reagents, Forecasted Estimates (till 2035)
• 21.2. Nucleic Acid Isolation and Purification Market in Europe: Distribution by Type of Nucleic Acid
  • 21.2.1. Nucleic Acid Isolation and Purification Market in Europe for DNA, Forecasted Estimates (till 2035)
  • 21.2.2. Nucleic Acid Isolation and Purification Market in Europe for RNA, Forecasted Estimates (till 2035)
• 21.3. Nucleic Acid Isolation and Purification Market in Europe: Distribution by Type of Solution
  • 21.3.1. Nucleic Acid Isolation and Purification Market in Europe for Manual Solutions, Forecasted Estimates (till 2035)
  • 21.3.2. Nucleic Acid Isolation and Purification Market in Europe for Automated Solutions, Forecasted Estimates (till 2035)
• 21.4. Nucleic Acid Isolation and Purification Market in Europe: Distribution by Type of Purification Method
  • 21.4.1. Nucleic Acid Isolation and Purification Market in Europe for Magnetic-based Methods, Forecasted Estimates (till 2035)
  • 21.4.2. Nucleic Acid Isolation and Purification Market in Europe for Column-based Methods, Forecasted Estimates (till 2035)
  • 21.4.3. Nucleic Acid Isolation and Purification Market in Europe for Reagent-based Methods, Forecasted Estimates (till 2035)
  • 21.4.4. Nucleic Acid Isolation and Purification Market in Europe for Other Methods, Forecasted Estimates (till 2035)
• 21.5. Nucleic Acid Isolation and Purification Market in Europe: Distribution by Type of Sample
  • 21.5.1. Nucleic Acid Isolation and Purification Market in Europe for Whole Blood Cells, Forecasted Estimates (till 2035)
  • 21.5.2. Nucleic Acid Isolation and Purification Market in Europe for Cultured Cells, Forecasted Estimates (till 2035)
  • 21.5.3. Nucleic Acid Isolation and Purification Market in Europe for Bacteria, Forecasted Estimates (till 2035)
  • 21.5.4. Nucleic Acid Isolation and Purification Market in Europe for Mammalian Cells, Forecasted Estimates (till 2035)
  • 21.5.5. Nucleic Acid Isolation and Purification Market in Europe for Yeast, Forecasted Estimates (till 2035)
  • 21.5.6. Nucleic Acid Isolation and Purification Market in Europe for FFPE, Forecasted Estimates (till 2035)
  • 21.5.7. Nucleic Acid Isolation and Purification Market in Europe for Brain and Kidney Tissues, Forecasted Estimates (till 2035)
  • 21.5.8. Nucleic Acid Isolation and Purification Market in Europe for Other Tissues, Forecasted Estimates (till 2035)
  • 21.5.9. Nucleic Acid Isolation and Purification Market in Europe for Plasma, Forecasted Estimates (till 2035)
  • 21.5.10. Nucleic Acid Isolation and Purification Market in Europe for Urine, Forecasted Estimates (till 2035)
  • 21.5.11. Nucleic Acid Isolation and Purification Market in Europe for Other Cell-free Samples, Forecasted Estimates (till 2035)
  • 21.5.12. Nucleic Acid Isolation and Purification Market in Europe for Saliva, Forecasted Estimates (till 2035)
  • 21.5.13. Nucleic Acid Isolation and Purification Market in Europe for Others, Forecasted Estimates (till 2035)
• 21.6. Nucleic Acid Isolation and Purification Market in Europe: Distribution by Type of Process
  • 21.6.1. Nucleic Acid Isolation and Purification Market in Europe for Upstream Processing, Forecasted Estimates (till 2035)
  • 21.6.2. Nucleic Acid Isolation and Purification Market in Europe for Downstream Processing, Forecasted Estimates (till 2035)
• 21.7. Nucleic Acid Isolation and Purification Market in Europe: Distribution by Type of Application
  • 21.7.1. Nucleic Acid Isolation and Purification Market in Europe for Oncology Testing, Forecasted Estimates (till 2035)
  • 21.7.2. Nucleic Acid Isolation and Purification Market in Europe for Oncology Research, Forecasted Estimates (till 2035)
  • 21.7.3. Nucleic Acid Isolation and Purification Market in Europe for Applied Testing, Forecasted Estimates (till 2035)
  • 21.7.4. Nucleic Acid Isolation and Purification Market in Europe for Human Identification (HID), Forecasted Estimates (till 2035)
  • 21.7.5. Nucleic Acid Isolation and Purification Market in Europe for Infectious Disease Testing, Forecasted Estimates (till 2035)
  • 21.7.6. Nucleic Acid Isolation and Purification Market in Europe for Microbiome Testing, Forecasted Estimates (till 2035)
  • 21.7.7. Nucleic Acid Isolation and Purification Market in Europe for Other Applications, Forecasted Estimates (till 2035)
• 21.8. Nucleic Acid Isolation and Purification Market in Europe: Distribution by End User
  • 21.8.1. Nucleic Acid Isolation and Purification Market in Europe for Biopharma End Users, Forecasted Estimates (till 2035)
  • 21.8.2. Nucleic Acid Isolation and Purification Market in Europe for Academic End Users, Forecasted Estimates (till 2035)

22. MARKET OPPORTUNITY ANALYSIS: ASIA-PACIFIC

• 22.1. Nucleic Acid Isolation and Purification Market in Asia-Pacific: Distribution by Type of Product
  • 22.1.1. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Kits, Forecasted Estimates (till 2035)
  • 22.1.2. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Instruments, Forecasted Estimates (till 2035)
  • 22.1.3. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Reagents, Forecasted Estimates (till 2035)
• 22.2. Nucleic Acid Isolation and Purification Market in Asia-Pacific: Distribution by Type of Nucleic Acid
  • 22.2.1. Nucleic Acid Isolation and Purification Market in Asia-Pacific for DNA, Forecasted Estimates (till 2035)
  • 22.2.2. Nucleic Acid Isolation and Purification Market in Asia-Pacific for RNA, Forecasted Estimates (till 2035)
• 22.3. Nucleic Acid Isolation and Purification Market in Asia-Pacific: Distribution by Type of Solution
  • 22.3.1. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Manual Solutions, Forecasted Estimates (till 2035)
  • 22.3.2. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Automated Solutions, Forecasted Estimates (till 2035)
• 22.4. Nucleic Acid Isolation and Purification Market in Asia-Pacific: Distribution by Type of Purification Method
  • 22.4.1. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Magnetic-based Methods, Forecasted Estimates (till 2035)
  • 22.4.2. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Column-based Methods, Forecasted Estimates (till 2035)
  • 22.4.3. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Reagent-based Methods, Forecasted Estimates (till 2035)
  • 22.4.4. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Other Methods, Forecasted Estimates (till 2035)
• 22.5. Nucleic Acid Isolation and Purification Market in Asia-Pacific: Distribution by Type of Sample
  • 22.5.1. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Whole Blood Cells, Forecasted Estimates (till 2035)
  • 22.5.2. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Cultured Cells, Forecasted Estimates (till 2035)
  • 22.5.3. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Bacteria, Forecasted Estimates (till 2035)
  • 22.5.4. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Mammalian Cells, Forecasted Estimates (till 2035)
  • 22.5.5. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Yeast, Forecasted Estimates (till 2035)
  • 22.5.6. Nucleic Acid Isolation and Purification Market in Asia-Pacific for FFPE, Forecasted Estimates (till 2035)
  • 22.5.7. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Brain and Kidney Tissues, Forecasted Estimates (till 2035)
  • 22.5.8. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Other Tissues, Forecasted Estimates (till 2035)
  • 22.5.9. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Plasma, Forecasted Estimates (till 2035)
  • 22.5.10. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Urine, Forecasted Estimates (till 2035)
  • 22.5.11. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Other Cell-free Samples, Forecasted Estimates (till 2035)
  • 22.5.12. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Saliva, Forecasted Estimates (till 2035)
  • 22.5.13. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Others, Forecasted Estimates (till 2035)
• 22.6. Nucleic Acid Isolation and Purification Market in Asia-Pacific: Distribution by Type of Process
  • 22.6.1. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Upstream Processing, Forecasted Estimates (till 2035)
  • 22.6.2. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Downstream Processing, Forecasted Estimates (till 2035)
• 22.7. Nucleic Acid Isolation and Purification Market in Asia-Pacific: Distribution by Type of Application
  • 22.7.1. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Oncology Testing, Forecasted Estimates (till 2035)
  • 22.7.2. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Oncology Research, Forecasted Estimates (till 2035)
  • 22.7.3. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Applied Testing, Forecasted Estimates (till 2035)
  • 22.7.4. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Human Identification (HID), Forecasted Estimates (till 2035)
  • 22.7.5. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Infectious Disease Testing, Forecasted Estimates (till 2035)
  • 22.7.6. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Microbiome Testing, Forecasted Estimates (till 2035)
  • 22.7.7. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Other Applications, Forecasted Estimates (till 2035)
• 22.8. Nucleic Acid Isolation and Purification Market in Asia-Pacific: Distribution by End User
  • 22.8.1. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Biopharma End Users, Forecasted Estimates (till 2035)
  • 22.8.2. Nucleic Acid Isolation and Purification Market in Asia-Pacific for Academic End Users, Forecasted Estimates (till 2035)

23. MARKET OPPORTUNITY ANALYSIS: MIDDLE EAST AND NORTH AFRICA

• 23.1. Nucleic Acid Isolation and Purification Market in Middle East and North Africa: Distribution by Type of Product
  • 23.1.1. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Kits, Forecasted Estimates (till 2035)
  • 23.1.2. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Instruments, Forecasted Estimates (till 2035)
  • 23.1.3. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Reagents, Forecasted Estimates (till 2035)
• 23.2. Nucleic Acid Isolation and Purification Market in Middle East and North Africa: Distribution by Type of Nucleic Acid
  • 23.2.1. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for DNA, Forecasted Estimates (till 2035)
  • 23.2.2. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for RNA, Forecasted Estimates (till 2035)
• 23.3. Nucleic Acid Isolation and Purification Market in Middle East and North Africa: Distribution by Type of Solution
  • 23.3.1. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Manual Solutions, Forecasted Estimates (till 2035)
  • 23.3.2. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Automated Solutions, Forecasted Estimates (till 2035)
• 23.4. Nucleic Acid Isolation and Purification Market in Middle East and North Africa: Distribution by Type of Purification Method
  • 23.4.1. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Magnetic-based Methods, Forecasted Estimates (till 2035)
  • 23.4.2. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Column-based Methods, Forecasted Estimates (till 2035)
  • 23.4.3. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Reagent-based Methods, Forecasted Estimates (till 2035)
  • 23.4.4. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Other Methods, Forecasted Estimates (till 2035)
• 23.5. Nucleic Acid Isolation and Purification Market in Middle East and North Africa: Distribution by Type of Sample
  • 23.5.1. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Whole Blood Cells, Forecasted Estimates (till 2035)
  • 23.5.2. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Cultured Cells, Forecasted Estimates (till 2035)
  • 23.5.3. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Bacteria, Forecasted Estimates (till 2035)
  • 23.5.4. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Mammalian Cells, Forecasted Estimates (till 2035)
  • 23.5.5. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Yeast, Forecasted Estimates (till 2035)
  • 23.5.6. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for FFPE, Forecasted Estimates (till 2035)
  • 23.5.7. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Brain and Kidney Tissues, Forecasted Estimates (till 2035)
  • 23.5.8. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Other Tissues, Forecasted Estimates (till 2035)
  • 23.5.9. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Plasma, Forecasted Estimates (till 2035)
  • 23.5.10. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Urine, Forecasted Estimates (till 2035)
  • 23.5.11. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Other Cell-free Samples, Forecasted Estimates (till 2035)
  • 23.5.12. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Saliva, Forecasted Estimates (till 2035)
  • 23.5.13. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Others, Forecasted Estimates (till 2035)
• 23.6. Nucleic Acid Isolation and Purification Market in Middle East and North Africa: Distribution by Type of Process
  • 23.6.1. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Upstream Processing, Forecasted Estimates (till 2035)
  • 23.6.2. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Downstream Processing, Forecasted Estimates (till 2035)
• 23.7. Nucleic Acid Isolation and Purification Market in Middle East and North Africa: Distribution by Type of Application
  • 23.7.1. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Oncology Testing, Forecasted Estimates (till 2035)
  • 23.7.2. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Oncology Research, Forecasted Estimates (till 2035)
  • 23.7.3. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Applied Testing, Forecasted Estimates (till 2035)
  • 23.7.4. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Human Identification (HID), Forecasted Estimates (till 2035)
  • 23.7.5. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Infectious Disease Testing, Forecasted Estimates (till 2035)
  • 23.7.6. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Microbiome Testing, Forecasted Estimates (till 2035)
  • 23.7.7. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Other Applications, Forecasted Estimates (till 2035)
• 23.8. Nucleic Acid Isolation and Purification Market in Middle East and North Africa: Distribution by End User
  • 23.8.1. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Biopharma End Users, Forecasted Estimates (till 2035)
  • 23.8.2. Nucleic Acid Isolation and Purification Market in Middle East and North Africa for Academic End Users, Forecasted Estimates (till 2035)

24. MARKET OPPORTUNITY ANALYSIS: LATIN AMERICA

• 24.1. Nucleic Acid Isolation and Purification Market in Latin America: Distribution by Type of Product
  • 24.1.1. Nucleic Acid Isolation and Purification Market in Latin America for Kits, Forecasted Estimates (till 2035)
  • 24.1.2. Nucleic Acid Isolation and Purification Market in Latin America for Instruments, Forecasted Estimates (till 2035)
  • 24.1.3. Nucleic Acid Isolation and Purification Market in Latin America for Reagents, Forecasted Estimates (till 2035)
• 24.2. Nucleic Acid Isolation and Purification Market in Latin America: Distribution by Type of Nucleic Acid
  • 24.2.1. Nucleic Acid Isolation and Purification Market in Latin America for DNA, Forecasted Estimates (till 2035)
  • 24.2.2. Nucleic Acid Isolation and Purification Market in Latin America for RNA, Forecasted Estimates (till 2035)
• 24.3. Nucleic Acid Isolation and Purification Market in Latin America: Distribution by Type of Solution
  • 24.3.1. Nucleic Acid Isolation and Purification Market in Latin America for Manual Solutions, Forecasted Estimates (till 2035)
  • 24.3.2. Nucleic Acid Isolation and Purification Market in Latin America for Automated Solutions, Forecasted Estimates (till 2035)
• 24.4. Nucleic Acid Isolation and Purification Market in Latin America: Distribution by Type of Purification Method
  • 24.4.1. Nucleic Acid Isolation and Purification Market in Latin America for Magnetic-based Methods, Forecasted Estimates (till 2035)
  • 24.4.2. Nucleic Acid Isolation and Purification Market in Latin America for Column-based Methods, Forecasted Estimates (till 2035)
  • 24.4.3. Nucleic Acid Isolation and Purification Market in Latin America for Reagent-based Methods, Forecasted Estimates (till 2035)
  • 24.4.4. Nucleic Acid Isolation and Purification Market in Latin America for Other Methods, Forecasted Estimates (till 2035)
• 24.5. Nucleic Acid Isolation and Purification Market in Latin America: Distribution by Type of Sample
  • 24.5.1. Nucleic Acid Isolation and Purification Market in Latin America for Whole Blood Cells, Forecasted Estimates (till 2035)
  • 24.5.2. Nucleic Acid Isolation and Purification Market in Latin America for Cultured Cells, Forecasted Estimates (till 2035)
  • 24.5.3. Nucleic Acid Isolation and Purification Market in Latin America for Bacteria, Forecasted Estimates (till 2035)
  • 24.5.4. Nucleic Acid Isolation and Purification Market in Latin America for Mammalian Cells, Forecasted Estimates (till 2035)
  • 24.5.5. Nucleic Acid Isolation and Purification Market in Latin America for Yeast, Forecasted Estimates (till 2035)
  • 24.5.6. Nucleic Acid Isolation and Purification Market in Latin America for FFPE, Forecasted Estimates (till 2035)
  • 24.5.7. Nucleic Acid Isolation and Purification Market in Latin America for Brain and Kidney Tissues, Forecasted Estimates (till 2035)
  • 24.5.8. Nucleic Acid Isolation and Purification Market in Latin America for Other Tissues, Forecasted Estimates (till 2035)
  • 24.5.9. Nucleic Acid Isolation and Purification Market in Latin America for Plasma, Forecasted Estimates (till 2035)
  • 24.5.10. Nucleic Acid Isolation and Purification Market in Latin America for Urine, Forecasted Estimates (till 2035)
  • 24.5.11. Nucleic Acid Isolation and Purification Market in Latin America for Other Cell-free Samples, Forecasted Estimates (till 2035)
  • 24.5.12. Nucleic Acid Isolation and Purification Market in Latin America for Saliva, Forecasted Estimates (till 2035)
  • 24.5.13. Nucleic Acid Isolation and Purification Market in Latin America for Others, Forecasted Estimates (till 2035)
• 24.6. Nucleic Acid Isolation and Purification Market in Latin America: Distribution by Type of Process
  • 24.6.1. Nucleic Acid Isolation and Purification Market in Latin America for Upstream Processing, Forecasted Estimates (till 2035)
  • 24.6.2. Nucleic Acid Isolation and Purification Market in Latin America for Downstream Processing, Forecasted Estimates (till 2035)
• 24.7. Nucleic Acid Isolation and Purification Market in Latin America: Distribution by Type of Application
  • 24.7.1. Nucleic Acid Isolation and Purification Market in Latin America for Oncology Testing, Forecasted Estimates (till 2035)
  • 24.7.2. Nucleic Acid Isolation and Purification Market in Latin America for Oncology Research, Forecasted Estimates (till 2035)
  • 24.7.3. Nucleic Acid Isolation and Purification Market in Latin America for Applied Testing, Forecasted Estimates (till 2035)
  • 24.7.4. Nucleic Acid Isolation and Purification Market in Latin America for Human Identification (HID), Forecasted Estimates (till 2035)
  • 24.7.5. Nucleic Acid Isolation and Purification Market in Latin America for Infectious Disease Testing, Forecasted Estimates (till 2035)
  • 24.7.6. Nucleic Acid Isolation and Purification Market in Latin America for Microbiome Testing, Forecasted Estimates (till 2035)
  • 24.7.7. Nucleic Acid Isolation and Purification Market in Latin America for Other Applications, Forecasted Estimates (till 2035)
• 24.8. Nucleic Acid Isolation and Purification Market in Latin America: Distribution by End User
  • 24.8.1. Nucleic Acid Isolation and Purification Market in Latin America for Biopharma End Users, Forecasted Estimates (till 2035)
  • 24.8.2. Nucleic Acid Isolation and Purification Market in Latin America for Academic End Users, Forecasted Estimates (till 2035)
• *Detailed information on Section VI is available in the Excel Data Packs shared along with the report**

25. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY LEADING PLAYERS

• 25.1. Key Assumptions and Methodology
• 25.2. Nucleic Acid Isolation and Purification Market: Distribution by Leading Players
  • 25.2.1. Nucleic Acid Isolation and Purification Market for Leading Player 1
  • 25.2.2. Nucleic Acid Isolation and Purification Market for Leading Player 2
  • 25.2.3. Nucleic Acid Isolation and Purification Market for Leading Player 3
  • 25.2.4. Nucleic Acid Isolation and Purification Market for Leading Player 4
  • 25.2.5. Nucleic Acid Isolation and Purification Market for Leading Player 5
  • 25.2.6. Nucleic Acid Isolation and Purification Market for Leading Player 6
  • 25.2.7. Nucleic Acid Isolation and Purification Market for Leading Player 7
  • 25.2.8. Nucleic Acid Isolation and Purification Market for Leading Player 8
• 25.3. Data Triangulation and Validation

26. CONCLUDING REMARKS

27. APPENDIX I: TABULATED DATA

28. APPENDIX II: LIST OF COMPANIES

관련자료